Neuralstem Inc to Present Positive Updated Data from Phase 2 Study of NSI-189 at the 56th American College of Neuropsychopharmac
Conference Call Neuralstem Inc
Neuralstem Inc Conference call will be held on Dec 5, 2017. During the earnings conference call's session Neuralstem Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Neuralstem Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are focused on the research and development of nervous system therapies based on our proprietary human neuronal stem cells and our small molecule compounds with the ultimate goal of gaining approval from the United States Food and Drug Administration or FDA, and its international counterparts to market and commercialize such therapies. We are headquartered in Germantown, Maryland. Our technology base has produced three primary assets: our NSI-189 small molecule program, our NSI-566 stem cell therapy program and our novel and proprietary new chemical entity screening platform. Our patented technologies enable the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the potential treatment of central nervous system diseases and conditions.Read more Conference Call